Maftivimab (REGN3470-3471-3479), also known as Atoltivimab, Odesivimab (Inmazeb), is a Filovirus inhibitor and a Food and Drug Administration (FDA)-approved agent for the research of Zaire ebolavirus infection [1].
CAS Number:
[2135632-36-7]
Target:
Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted
